Stock Information
Palvella Therapeutics Inc (PVLA)
Ticker Symbol: PVLA
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,461.33 mil
Piotroski score: 1
PE Ratio: N/A
EPS (TTM): -3.8275
Revenue (TTM): $0.76 M
Dividend Yield: N/A%
ROE: -68.42%
Latest News
-
Chardan Capital Maintains Buy on Palvella Therapeutics, Raises Price Target to $240
Tue, Mar 31, 2026 5:09 PM
-
Palvella Therapeutics shares are trading higher. The company reported its Q4 financial results.
Tue, Mar 31, 2026 12:35 PM
-
Palvella Therapeutics Q4 EPS $(1.08) Misses $(0.91) Estimate
Tue, Mar 31, 2026 7:31 AM
-
Earnings Scheduled For March 31, 2026
Tue, Mar 31, 2026 7:11 AM
-
Palvella Therapeutics Publishes Comprehensive Review Article Titled Microcystic and Macrocystic Lymphatic Malformations: Distinct Genetics And Clinical Strategies
Mon, Mar 30, 2026 7:36 AM
Key Financials
Financial data not available
